- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Pricing
- SKY Learn
- Mutual Funds
- Margin Trading
- Financial Planning
- Personal Finance
- Share Trading
- IPO
- Derivatives
- Currencies
- Intraday Trading
- Trading Strategies
- Demat Account
- Commodity
- ETF
Sector: Pharmaceuticals & Biotechnology
|Large Cap
AstraZeneca Pharma Share Price
AstraZeneca Pharma India Ltd.
₹7,871.50
106.00(1.37%)
Invest in ASTRAZEN with up to 2.50x margin.
Trade with MTF1st Apr 2026 | 1:01 PM
NSE : ASTRAZEN
Open Free Demat Account
AstraZeneca Pharma Performance
Price Movement
₹7871.50
₹7755.50
₹7997.00
↘ Today's Low↗ Today's High
1 Year Performance
₹7871.50
₹7201.15
₹10691.00
↘ 52 Week Low↗ 52 Week High
Markets Today
High₹7,997.00
Low₹7,755.50
Open at₹7,970.00
Prev Close₹7,765.50
Volumes4.32 K
Avg Price₹7,844.31
Lower Circuit₹6,212.50
Upper Circuit₹9,318.50
Historical Performance
3M High₹9,220.00
3M Low₹7,677.00
1 Yr High₹10,691.00
1 Yr Low₹7,201.15
3 Yr High₹10,691.00
3 Yr Low₹3,098.00
5 Yr High₹10,691.00
5 Yr Low₹2,445.70
AstraZeneca Pharma Fundamentals
Market Cap
High in industry
19,413.80 Cr.
PE Ratio (TTM)
High in industry
96.60
Dividend Yield
Below industry Median
0.40
Net Profit TTM
107.2% incr over last year
200.89
Net Profit Growth
107.2% incr over last year
200.89
PEG Ratio
Above industry Median
0.90
ROE
34% decr over last year
15.02
Operating Revenue TTM
2,177.45
Operating Revenue Growth
34.5% incr over last year
Book Value
High in industry
23.30
MFI
MFI strongly Oversold
15.85
RSI
RSI oversold
28.23
EPS (TTM)
-
Debt to Equity
-
Face Value
-
Operating Profit Margin Qtr.
-
Operating Profit Qtr.
-
Net Profit Qtr.
-
Operating Revenue Qtr.
-
PB Ratio
23.30
AstraZeneca Pharma Financials
*All values are in Rs. Cr
Loading chart...
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 611.57 | 559.09 | 526.31 | 480.48 | 440.29 |
| Operating Expense | 566.74 | 483.91 | 445.20 | 394.11 | 363.47 |
| Operating Profit | 44.83 | 75.18 | 81.11 | 86.37 | 76.99 |
| Depreciation | 3.84 | 2.57 | 16.57 | 17.69 | 9.07 |
| Interest | 1.06 | 0.67 | 0.72 | 0.68 | 0.33 |
| Tax | 13.95 | 18.60 | 18.87 | 20.22 | 11.17 |
| Net Profit | 32.59 | 54.22 | 55.83 | 58.25 | 30.85 |
AstraZeneca Pharma Technicals
AstraZeneca Pharma India Ltd. EMA & SMA
₹7871.50
-59.50 (-0.75%)
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
Day EMA5 ₹8059.3
Day EMA10 ₹8218.8
Day EMA12 ₹8264.4
Day EMA20 ₹8390.5
Day EMA26 ₹8448.1
Day EMA50 ₹8573.1
Day EMA100 ₹8692.2
Day EMA200 ₹8630.2
AstraZeneca Pharma Support and Resistance
Resistance
First Resistance₹7885.67
Second Resistance₹8005.83
Third Resistance₹8110.17
Support
First Support₹7661.17
Second Support₹7556.83
Third Support₹7436.67
Technical Indicators
Day RSI28.23
Day MFI15.85
Day ADX30.90
Day Commodity Channel Index-222.30
William-92.52
Day MACD-183.74
Day MACD Signal Line-113.63
Day ATR244.05
Day ROC125-13.98
Day ROC21-12.44
AstraZeneca Pharma Shareholding Pattern
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 2.9 | 2.9 | 2.9 | 3 | 2.7 | 2.7 |
| DII | 5.1 | 5.2 | 4.6 | 4.6 | 5.3 | 5.6 |
| Public | 17 | 16.8 | 17.4 | 17.4 | 17 | 16.7 |
AstraZeneca Pharma Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 8.03 K | 15.17 K | 52.92% |
| Week | 13.55 K | 22.37 K | 60.57% |
| 1 Month | 5.47 K | 9.65 K | 56.71% |
| 6 Month | 5.41 K | 10.84 K | 49.86% |
AstraZeneca Pharma SWOT Analysis
Strengths9
Weakness11
Opportunity5
Threats2
Companies with no Debt
Benjamin Graham Value Screen
Rising Net Cash Flow and Cash from Operating activity
Expensive Performers (DVM)
PEG lower than Industry PEG
Increasing Revenue every Quarter for the past 8 Quarters
Increasing Revenue every Quarter for the past 4 Quarters
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
AstraZeneca Pharma Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 18 Jul, 2025 | 32 | FINAL | 18 Jul, 2025 | Equity Share |
| 05 Jul, 2024 | 24 | FINAL | 05 Jul, 2024 | Equity Share |
| 14 Jul, 2023 | 16 | FINAL | 14 Jul, 2023 | Equity Share |
| 07 Jul, 2022 | 8 | FINAL | 08 Jul, 2022 | Equity Share |
| 18 Aug, 2021 | 2 | INTERIM | 20 Aug, 2021 | Equity Share |
| 20 Aug, 2020 | 2 | INTERIM | 21 Aug, 2020 | Equity Share |
| 20 Aug, 2019 | 1 | INTERIM | 21 Aug, 2019 | Equity Share |
| 09 Jul, 2012 | 3.5 | FINAL | Equity Share | |
| 07 Jul, 2011 | 10 | FINAL | Equity Share | |
| 06 May, 2010 | 10 | FINAL | Equity Share |
AstraZeneca Pharma Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹674.40 | ₹974.60 | ₹1,598.50 | ₹1,995.20 | ₹1,722.90 | ₹1,042 |
| % Change | 2.77% | 0.27% | 0.19% | -0.53% | 1.58% | 4.97% |
| Revenue TTM (₹ Cr) | ₹1,996.59 | ₹2,169.86 | ₹8,850.08 | ₹13,914.08 | ₹6,112.77 | ₹6,721.63 |
| Net Profit TTM (₹ Cr) | ₹484.66 | ₹332.94 | ₹869.92 | ₹1,779.35 | ₹847.18 | ₹843.32 |
| PE TTM | 76.10 | 61.80 | 34.80 | 46.50 | 33.00 | 63.50 |
| 1 Year Return | 15.13 | 27.75 | 48.78 | -17.28 | 6.51 | 61.84 |
| ROCE | 26.88 | 12.51 | 20.80 | 13.27 | 11.43 | 11.82 |
Similar Stocks
ALKEM
Alkem Laboratories Ltd.
₹ 5288.00
-0.21%
BIOCON
Biocon Ltd.
₹ 370.05
+2.54%
DIVISLAB
Divi's Laboratories Ltd.
₹ 5984.00
+0.62%
AJANTPHARM
Ajanta Pharma Ltd.
₹ 2838.80
+1.20%
ZYDUSLIFE
Zydus Lifesciences Ltd.
₹ 875.60
+0.51%
GLENMARK
Glenmark Pharmaceuticals Ltd.
₹ 2146.70
+0.70%
AUROPHARMA
Aurobindo Pharma Ltd.
₹ 1351.10
+3.58%
SUNPHARMA
Sun Pharmaceutical Industries Ltd.
₹ 1752.70
-0.26%
IPCALAB
Ipca Laboratories Ltd.
₹ 1570.00
-1.95%
JBCHEPHARM
J B Chemicals & Pharmaceuticals Ltd.
₹ 2025.40
-1.89%
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2345.00
+2.72%
PFIZER
Pfizer Ltd.
₹ 4849.50
+2.73%
ABBOTINDIA
Abbott India Ltd.
₹ 26490.00
+2.22%
TORNTPHARM
Torrent Pharmaceuticals Ltd.
₹ 4185.40
-0.82%
LUPIN
Lupin Ltd.
₹ 2295.50
-0.80%
DRREDDY
Dr. Reddy's Laboratories Ltd.
₹ 1235.60
-1.54%
CIPLA
Cipla Ltd.
₹ 1208.40
-1.29%
FAQ's on ASTRAZEN
What is the current share price of AstraZeneca Pharma India Ltd.?
As of 6 June 2025 at 10:01 AM, the share price for AstraZeneca Pharma India Ltd. is ₹ 7871.5 on the NSE and ₹ 7871.5 on the BSE. (Note: Prices are dynamic and update frequently during market hours).
What is the Market Capitalization of AstraZeneca Pharma India Ltd.?
Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for AstraZeneca Pharma India Ltd. is approximately ₹ 19413.8 Cr.
What are the PE and PB ratios for AstraZeneca Pharma India Ltd.?
Based on recent data, the Price-to-Earnings (PE) ratio for AstraZeneca Pharma India Ltd. is 96.6, and the Price-to-Book (PB) ratio is 23.3.
What is the 52-Week High and Low for AstraZeneca Pharma India Ltd.?
Over the past 52 weeks, the highest price reached by AstraZeneca Pharma India Ltd. shares was ₹ 10691, and the lowest price was ₹ 7201.15.
What is the current dividend yield for AstraZeneca Pharma India Ltd.?
As of 6 June 2025, the dividend yield for AstraZeneca Pharma India Ltd. is 0.4%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.
Who are the major shareholders of AstraZeneca Pharma India Ltd.?
Significant shareholdings in AstraZeneca Pharma India Ltd. typically include entities such as:
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
- Promoter
- Public
- Mutual Funds
- FII
- Other Institutions
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
Who are the peers of AstraZeneca Pharma India Ltd. in the Pharmaceuticals & Biotechnology sector?
In the Pharmaceuticals & Biotechnology sector, AstraZeneca Pharma India Ltd. is often compared with other major players such as
Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.
What is the latest dividend information for AstraZeneca Pharma India Ltd.?
AstraZeneca Pharma India Ltd. last declared a FINAL dividend of ₹ 32 per share for the financial period ending 2025. The record date was set as 2025-07-18, and the payment was/is scheduled around 2025-07-18. For the most current dividend announcements, refer to official company filings.
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy